Clinical trials
Phase 2 Arrhythmias, Cardiac trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 5 |
| 2009 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Novartis Pharmaceuticals | 2 |
| Anthos Therapeutics, Inc. | 1 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| Inova Health Care Services | 1 |
| Massachusetts General Hospital | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Sanofi | 1 |
| University of Florida | 1 |
| University of Michigan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrhythmias, Cardiac | 15 |
| Atrial Fibrillation | 3 |
| Tachycardia, Ventricular | 2 |
| Anemia, Sickle Cell | 1 |
| Atrial Premature Complexes | 1 |
| Cardiomyopathies | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Cicatrix | 1 |
| Fibrosis | 1 |
| Heart Arrest | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.